Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Albertsons Companies, Inc.ACI · Entity 2116 | EVP, M&A and Corporate Affairs | September 08, 2026 | September 10, 2026 |
| CVS HEALTH CorpCVS · Entity 2884 | EVP & General Counsel | December 31, 2022 | January 04, 2023 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Albertsons Companies, Inc.
Report date September 08, 2026 · Filed September 10, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Time-based Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 164,745 |
Reported balance
After 2026-09-08 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-09-08 · Grant · Acquired 164,745 · Balance 164,745 F1: Each restricted stock unit represents a contractual right to receive one share of Class A common stock of Albertsons Companies, Inc. ("the Company"). This award will vest in three equal installments as follows: (a) one-third on September 8, 2027; (b) one-third on September 8, 2028; and (c) one-third on September 8, 2029, as long as the reporting person remains continuously employed through such dates. |
Filing footnotes · ownership attribution and instrument terms
F1: Each restricted stock unit represents a contractual right to receive one share of Class A common stock of Albertsons Companies, Inc. ("the Company"). This award will vest in three equal installments as follows: (a) one-third on September 8, 2027; (b) one-third on September 8, 2028; and (c) one-third on September 8, 2029, as long as the reporting person remains continuously employed through such dates.
CVS HEALTH Corp
Report date December 31, 2022 · Filed January 04, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 315,273.0221 |
Reported balance
After 2022-12-31 transaction · row 1
1 source rowRow 1 · 2022-12-31 · Tax withholding · Disposed 292,856 · Balance 315,273.0221 F1: Surrender of shares in payment of withholding taxes due upon the vesting and settlement of the PSUs. |
| Common StockSEC Table I · non-derivative | IndirectBy GRAT | 159,120 |
Reported balance
Holding disclosure · report date 2022-12-31 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 159,120 |
| Stock UnitSEC Table I · non-derivative | Direct | 47,325.339 |
Reported balance
Holding disclosure · report date 2022-12-31 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 47,325.339 |
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $104.82 · Expires 2023-04-01 | Direct | 71,696 |
Reported balance
Holding disclosure · report date 2022-12-31 · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · Balance 71,696 F2: Option became exercisable in four equal annual installments, commencing 4/1/2017. |
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $78.05 · Expires 2024-04-03 | Direct | 24,248 |
Reported balance
Holding disclosure · report date 2022-12-31 · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · Balance 24,248 F3: Option became exercisable in four equal annual installments, commencing 4/3/2018. |
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $54.19 · Expires 2029-04-01 | Direct | 50,502 |
Reported balance
Holding disclosure · report date 2022-12-31 · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · Balance 50,502 F4: Option became exercisable in four equal annual installments, commencing 4/1/2020. |
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $58.34 · Expires 2030-04-01 | Direct | 98,558 |
Reported balance
Holding disclosure · report date 2022-12-31 · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · Balance 98,558 F5: The number of shares subject to the option were calculated using a 30-day average price. F6: Option became exercisable in four equal annual installments, commencing 4/1/2021. |
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $74.30 · Expires 2031-04-01 | Direct | 116,622 |
Reported balance
Holding disclosure · report date 2022-12-31 · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · Balance 116,622 F7: Option became exercisable in four equal annual installments, commencing 4/1/2022. |
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $101.09 · Expires 2032-04-01 | Direct | 46,777 |
Reported balance
Holding disclosure · report date 2022-12-31 · row 9
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 9 · Balance 46,777 F8: Option becomes exercisable in four equal annual installments, commencing 4/1/2023. |
Filing footnotes · ownership attribution and instrument terms
F1: Surrender of shares in payment of withholding taxes due upon the vesting and settlement of the PSUs.
F2: Option became exercisable in four equal annual installments, commencing 4/1/2017.
F3: Option became exercisable in four equal annual installments, commencing 4/3/2018.
F4: Option became exercisable in four equal annual installments, commencing 4/1/2020.
F5: The number of shares subject to the option were calculated using a 30-day average price.
F6: Option became exercisable in four equal annual installments, commencing 4/1/2021.
F7: Option became exercisable in four equal annual installments, commencing 4/1/2022.
F8: Option becomes exercisable in four equal annual installments, commencing 4/1/2023.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 24, 2024 Filed Apr 27, 2024 00:06 UTC | Albertsons Companies, Inc. ACI · Entity 2116 | GrantPerformance-based Restricted Stock Units · Derivative | 87,238 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001646972-24-000105 · wk-form4_1714176369.xml · derivative · entry 2 Moriarty Thomas M · CIK 0001412221 · EVP General Counsel & CPO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 87,238 Underlying: Class A common stock par value $0.01 · 87,238 shares Expires not disclosed F2 · derivative.exercise_price: Each performance-based restricted stock unit represents a contractual right to receive one share of Class A common stock of the Company. These performance-based restricted stock units are subject to the attainment of performance goals for the 2024, 2025 and 2026 fiscal years of the Company. The reported number of performance restricted stock units represents the "target" amount of the award and the actual number of units earned will depend upon satisfaction of the performance goals. F2 · price: Each performance-based restricted stock unit represents a contractual right to receive one share of Class A common stock of the Company. These performance-based restricted stock units are subject to the attainment of performance goals for the 2024, 2025 and 2026 fiscal years of the Company. The reported number of performance restricted stock units represents the "target" amount of the award and the actual number of units earned will depend upon satisfaction of the performance goals. F2 · derivative.exercise_date: Each performance-based restricted stock unit represents a contractual right to receive one share of Class A common stock of the Company. These performance-based restricted stock units are subject to the attainment of performance goals for the 2024, 2025 and 2026 fiscal years of the Company. The reported number of performance restricted stock units represents the "target" amount of the award and the actual number of units earned will depend upon satisfaction of the performance goals. F2 · derivative.expiration_date: Each performance-based restricted stock unit represents a contractual right to receive one share of Class A common stock of the Company. These performance-based restricted stock units are subject to the attainment of performance goals for the 2024, 2025 and 2026 fiscal years of the Company. The reported number of performance restricted stock units represents the "target" amount of the award and the actual number of units earned will depend upon satisfaction of the performance goals. Read SEC document |
| April 24, 2024 Filed Apr 27, 2024 00:06 UTC | Albertsons Companies, Inc. ACI · Entity 2116 | GrantTime-based Restricted Stock Units · Derivative | 87,239 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001646972-24-000105 · wk-form4_1714176369.xml · derivative · entry 1 Moriarty Thomas M · CIK 0001412221 · EVP General Counsel & CPO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 87,239 Underlying: Class A common stock par value $0.01 · 87,239 shares Expires not disclosed F1 · derivative.exercise_price: Each time-based restricted stock unit represents a contractual right to receive one share of Class A common stock of Albertsons Companies, Inc. (the "Company"). The award will vest in three equal installments on February 22, 2025, February 28, 2026 and February 27, 2027, as long as the reporting person remains continuously employed through such respective date. F1 · price: Each time-based restricted stock unit represents a contractual right to receive one share of Class A common stock of Albertsons Companies, Inc. (the "Company"). The award will vest in three equal installments on February 22, 2025, February 28, 2026 and February 27, 2027, as long as the reporting person remains continuously employed through such respective date. F1 · derivative.exercise_date: Each time-based restricted stock unit represents a contractual right to receive one share of Class A common stock of Albertsons Companies, Inc. (the "Company"). The award will vest in three equal installments on February 22, 2025, February 28, 2026 and February 27, 2027, as long as the reporting person remains continuously employed through such respective date. F1 · derivative.expiration_date: Each time-based restricted stock unit represents a contractual right to receive one share of Class A common stock of Albertsons Companies, Inc. (the "Company"). The award will vest in three equal installments on February 22, 2025, February 28, 2026 and February 27, 2027, as long as the reporting person remains continuously employed through such respective date. Read SEC document |
| February 26, 2024 Filed Feb 28, 2024 02:20 UTC | Albertsons Companies, Inc. ACI · Entity 2116 | Exercise / conversionTime-based Restricted Stock Units · Derivative | 27,073 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001646972-24-000030 · wk-form4_1709086835.xml · derivative · entry 3 Moriarty Thomas M · CIK 0001412221 · EVP General Counsel & CPO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 54,147 Underlying: Class A common stock par value $0.01 · 27,073 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each time-based restricted stock unit represents a contractual right to receive one share of Class A common stock of Albertsons Companies, Inc. This award will vest in three equal installments on February 24, 2024, February 22, 2025 and February 28, 2026 as long as the reporting person remains continuously employed through such respective date. F2 · price: Each time-based restricted stock unit represents a contractual right to receive one share of Class A common stock of Albertsons Companies, Inc. This award will vest in three equal installments on February 24, 2024, February 22, 2025 and February 28, 2026 as long as the reporting person remains continuously employed through such respective date. F2 · derivative.exercise_date: Each time-based restricted stock unit represents a contractual right to receive one share of Class A common stock of Albertsons Companies, Inc. This award will vest in three equal installments on February 24, 2024, February 22, 2025 and February 28, 2026 as long as the reporting person remains continuously employed through such respective date. F2 · derivative.expiration_date: Each time-based restricted stock unit represents a contractual right to receive one share of Class A common stock of Albertsons Companies, Inc. This award will vest in three equal installments on February 24, 2024, February 22, 2025 and February 28, 2026 as long as the reporting person remains continuously employed through such respective date. Read SEC document |
| February 26, 2024 Filed Feb 28, 2024 02:20 UTC | Albertsons Companies, Inc. ACI · Entity 2116 | Tax withholdingClass A common stock, par value $0.01 per share | 12,704 | $21.44 | $272,373.76 |
DisclosureSEC source: 0001646972-24-000030 · wk-form4_1709086835.xml · nonDerivative · entry 2 Moriarty Thomas M · CIK 0001412221 · EVP General Counsel & CPO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,369 Read SEC document |
| February 26, 2024 Filed Feb 28, 2024 02:20 UTC | Albertsons Companies, Inc. ACI · Entity 2116 | Exercise / conversionClass A common stock, par value $0.01 per share | 27,073 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001646972-24-000030 · wk-form4_1709086835.xml · nonDerivative · entry 1 Moriarty Thomas M · CIK 0001412221 · EVP General Counsel & CPO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,073 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contractual right to receive one share of Class A common stock of Albertsons Companies, Inc. Read SEC document |
| February 09, 2024 Filed Feb 14, 2024 00:24 UTC | Albertsons Companies, Inc. ACI · Entity 2116 | GrantDividend Equivalent Units · Derivative | 457 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-24-003263 · doc4.xml · derivative · entry 1 Moriarty Thomas M · CIK 0001412221 · EVP General Counsel & CPO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 81,220 Underlying: Class A common stock, par value $0.01 · 457 shares Expires not disclosed F1 · derivative.exercise_price: Restricted stock units ("RSUs") credited to the reporting person's account as dividend equivalents on unvested RSUs and will vest and settle with the underlying awards. The reported number is the quarterly dividend equivalent to $0.12 per share of common stock. F1 · shares: Restricted stock units ("RSUs") credited to the reporting person's account as dividend equivalents on unvested RSUs and will vest and settle with the underlying awards. The reported number is the quarterly dividend equivalent to $0.12 per share of common stock. F1 · derivative.exercise_date: Restricted stock units ("RSUs") credited to the reporting person's account as dividend equivalents on unvested RSUs and will vest and settle with the underlying awards. The reported number is the quarterly dividend equivalent to $0.12 per share of common stock. F1 · derivative.expiration_date: Restricted stock units ("RSUs") credited to the reporting person's account as dividend equivalents on unvested RSUs and will vest and settle with the underlying awards. The reported number is the quarterly dividend equivalent to $0.12 per share of common stock. Read SEC document |
| November 14, 2023 Filed Nov 15, 2023 22:25 UTC | Albertsons Companies, Inc. ACI · Entity 2116 | GrantDividend Equivalent Units · Derivative | 451 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-055398 · doc4.xml · derivative · entry 1 Moriarty Thomas M · CIK 0001412221 · EVP General Counsel & CPO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 80,763 Underlying: Class A common stock par value $0.01 · 451 shares Expires not disclosed F1 · derivative.exercise_price: Restricted stock units ("RSUs") credited to the reporting person's account as dividend equivalents on unvested RSUs and will vest and settle with the underlying awards. The reported number is the quarterly dividend equivalent of $0.12 per share of common stock. F1 · shares: Restricted stock units ("RSUs") credited to the reporting person's account as dividend equivalents on unvested RSUs and will vest and settle with the underlying awards. The reported number is the quarterly dividend equivalent of $0.12 per share of common stock. F1 · derivative.exercise_date: Restricted stock units ("RSUs") credited to the reporting person's account as dividend equivalents on unvested RSUs and will vest and settle with the underlying awards. The reported number is the quarterly dividend equivalent of $0.12 per share of common stock. F1 · derivative.expiration_date: Restricted stock units ("RSUs") credited to the reporting person's account as dividend equivalents on unvested RSUs and will vest and settle with the underlying awards. The reported number is the quarterly dividend equivalent of $0.12 per share of common stock. Read SEC document |
| August 10, 2023 Filed Aug 15, 2023 00:53 UTC | Albertsons Companies, Inc. ACI · Entity 2116 | GrantDividend Equivalent Units · Derivative | 440 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-045757 · doc4.xml · derivative · entry 1 Moriarty Thomas M · CIK 0001412221 · EVP General Counsel & CPO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 80,312 Underlying: Class A common stock par value $0.01 · 440 shares Expires not disclosed F1 · derivative.exercise_price: Restricted stock units ("RSUs") credited to the reporting person's account as dividend equivalents on unvested RSUs and will vest and settle with the underlying awards. The reported number is the quarterly dividend equivalent to $0.12 per share of common stock. F1 · shares: Restricted stock units ("RSUs") credited to the reporting person's account as dividend equivalents on unvested RSUs and will vest and settle with the underlying awards. The reported number is the quarterly dividend equivalent to $0.12 per share of common stock. F1 · derivative.exercise_date: Restricted stock units ("RSUs") credited to the reporting person's account as dividend equivalents on unvested RSUs and will vest and settle with the underlying awards. The reported number is the quarterly dividend equivalent to $0.12 per share of common stock. F1 · derivative.expiration_date: Restricted stock units ("RSUs") credited to the reporting person's account as dividend equivalents on unvested RSUs and will vest and settle with the underlying awards. The reported number is the quarterly dividend equivalent to $0.12 per share of common stock. Read SEC document |
| July 03, 2023 Filed Jul 6, 2023 14:47 UTC | Albertsons Companies, Inc. ACI · Entity 2116 | GrantPerformance-Based Restricted Stock Units · Derivative | 79,872 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-23-041444 · doc4.xml · derivative · entry 2 Moriarty Thomas M · CIK 0001412221 · EVP General Counsel & CPO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 79,872 Underlying: Class A common stock par value $0.01 · 79,872 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contractual right to receive one share of Class A common stock of the Company. These restricted stock units are subject to the attainment of performance goals for the 2023, 2024 and 2025 fiscal years of the Company. The reported number of restricted stock units represents the "target" amount of the award and the actual number of units earned will depend upon satisfaction of the performance goals. F2 · price: Each restricted stock unit represents a contractual right to receive one share of Class A common stock of the Company. These restricted stock units are subject to the attainment of performance goals for the 2023, 2024 and 2025 fiscal years of the Company. The reported number of restricted stock units represents the "target" amount of the award and the actual number of units earned will depend upon satisfaction of the performance goals. F2 · derivative.exercise_date: Each restricted stock unit represents a contractual right to receive one share of Class A common stock of the Company. These restricted stock units are subject to the attainment of performance goals for the 2023, 2024 and 2025 fiscal years of the Company. The reported number of restricted stock units represents the "target" amount of the award and the actual number of units earned will depend upon satisfaction of the performance goals. F2 · derivative.expiration_date: Each restricted stock unit represents a contractual right to receive one share of Class A common stock of the Company. These restricted stock units are subject to the attainment of performance goals for the 2023, 2024 and 2025 fiscal years of the Company. The reported number of restricted stock units represents the "target" amount of the award and the actual number of units earned will depend upon satisfaction of the performance goals. Read SEC document |
| July 03, 2023 Filed Jul 6, 2023 14:47 UTC | Albertsons Companies, Inc. ACI · Entity 2116 | GrantTime-Based Restricted Stock Units · Derivative | 79,872 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-23-041444 · doc4.xml · derivative · entry 1 Moriarty Thomas M · CIK 0001412221 · EVP General Counsel & CPO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 79,872 Underlying: Class A common stock par value $0.01 · 79,872 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contractual right to receive one share of Class A common stock of Albertsons Companies, Inc. ("the Company"). This award will vest in three equal installments on the last day of each of the next three (3) fiscal years of the Company as follows: (a) one-third on February 24, 2024; (b) one-third on February 22, 2025; and (c) one-third on February 28, 2026, as long as the reporting person remains continuously employed through such date. F1 · price: Each restricted stock unit represents a contractual right to receive one share of Class A common stock of Albertsons Companies, Inc. ("the Company"). This award will vest in three equal installments on the last day of each of the next three (3) fiscal years of the Company as follows: (a) one-third on February 24, 2024; (b) one-third on February 22, 2025; and (c) one-third on February 28, 2026, as long as the reporting person remains continuously employed through such date. F1 · derivative.exercise_date: Each restricted stock unit represents a contractual right to receive one share of Class A common stock of Albertsons Companies, Inc. ("the Company"). This award will vest in three equal installments on the last day of each of the next three (3) fiscal years of the Company as follows: (a) one-third on February 24, 2024; (b) one-third on February 22, 2025; and (c) one-third on February 28, 2026, as long as the reporting person remains continuously employed through such date. F1 · derivative.expiration_date: Each restricted stock unit represents a contractual right to receive one share of Class A common stock of Albertsons Companies, Inc. ("the Company"). This award will vest in three equal installments on the last day of each of the next three (3) fiscal years of the Company as follows: (a) one-third on February 24, 2024; (b) one-third on February 22, 2025; and (c) one-third on February 28, 2026, as long as the reporting person remains continuously employed through such date. Read SEC document |
| December 31, 2022 Filed Jan 4, 2023 21:16 UTC | CVS HEALTH Corp CVS · Entity 2884 | Tax withholdingCommon Stock | 292,856 | $93.19 | $27,291,250.64 |
DisclosureSEC source: 0001127602-23-000476 · form4.xml · nonDerivative · entry 1 Moriarty Thomas M · CIK 0001412221 · EVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 315,273.0221 F1 · shares: Surrender of shares in payment of withholding taxes due upon the vesting and settlement of the PSUs. Read SEC document |
| December 15, 2022 Filed Dec 16, 2022 21:14 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionStock Option · Derivative | 36,490 | $0.00 Strike: $62.21 | $0.00 |
DisclosureSEC source: 0001127602-22-027664 · form4.xml · derivative · entry 13 Moriarty Thomas M · CIK 0001412221 · EVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 36,490 shares Expires 2025-04-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: Option became exercisable in four equal annual installments, commencing 4/1/2019. Read SEC document |
| December 15, 2022 Filed Dec 16, 2022 21:14 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionStock Option · Derivative | 100,976 | $0.00 Strike: $78.05 | $0.00 |
DisclosureSEC source: 0001127602-22-027664 · form4.xml · derivative · entry 12 Moriarty Thomas M · CIK 0001412221 · EVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,248 Underlying: Common Stock · 100,976 shares Expires 2024-04-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Option became exercisable in four equal annual installments, commencing 4/3/2018. Read SEC document |
| December 15, 2022 Filed Dec 16, 2022 21:14 UTC | CVS HEALTH Corp CVS · Entity 2884 | SaleCommon Stock | 36,490 | $98.24 | $3,584,868.83 |
DisclosureSEC source: 0001127602-22-027664 · form4.xml · nonDerivative · entry 4 Moriarty Thomas M · CIK 0001412221 · EVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 608,129.0221 F2 · kind: All sales were effected pursuant to a Rule 10b5-1 plan. Read SEC document |
| December 15, 2022 Filed Dec 16, 2022 21:14 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionCommon Stock | 36,490 | $62.21 | $2,270,042.90 |
DisclosureSEC source: 0001127602-22-027664 · form4.xml · nonDerivative · entry 3 Moriarty Thomas M · CIK 0001412221 · EVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 644,619.0221 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 15, 2022 Filed Dec 16, 2022 21:14 UTC | CVS HEALTH Corp CVS · Entity 2884 | SaleCommon Stock | 100,976 | $98.40 | $9,936,311.04 |
DisclosureSEC source: 0001127602-22-027664 · form4.xml · nonDerivative · entry 2 Moriarty Thomas M · CIK 0001412221 · EVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 608,129.0221 F1 · kind: All sales were effected pursuant to a Rule 10b5-1 plan. Read SEC document |
| December 15, 2022 Filed Dec 16, 2022 21:14 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionCommon Stock | 100,976 | $78.05 | $7,881,176.80 |
DisclosureSEC source: 0001127602-22-027664 · form4.xml · nonDerivative · entry 1 Moriarty Thomas M · CIK 0001412221 · EVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 709,105.0221 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 28, 2022 Filed Jun 30, 2022 21:00 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionStock Option · Derivative | 38,873 | $0.00 Strike: $74.30 | $0.00 |
DisclosureSEC source: 0001127602-22-018293 · form4.xml · derivative · entry 9 Moriarty Thomas M · CIK 0001412221 · EVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 116,622 Underlying: Common Stock · 38,873 shares Expires 2031-04-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · security: Option became exercisable in four equal annual installments, commencing 4/1/2022. Read SEC document |
| June 28, 2022 Filed Jun 30, 2022 21:00 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionStock Option · Derivative | 50,502 | $0.00 Strike: $54.19 | $0.00 |
DisclosureSEC source: 0001127602-22-018293 · form4.xml · derivative · entry 8 Moriarty Thomas M · CIK 0001412221 · EVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,502 Underlying: Common Stock · 50,502 shares Expires 2029-04-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: Option became exercisable in four equal annual installments, commencing 4/1/2020. Read SEC document |
| June 28, 2022 Filed Jun 30, 2022 21:00 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionStock Option · Derivative | 49,279 | $0.00 Strike: $58.34 | $0.00 |
DisclosureSEC source: 0001127602-22-018293 · form4.xml · derivative · entry 7 Moriarty Thomas M · CIK 0001412221 · EVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 98,558 Underlying: Common Stock · 49,279 shares Expires 2030-04-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: The number of shares subject to the option were calculated using a 30-day average price. F3 · derivative.exercise_date: Option became exercisable in four equal annual installments, commencing 4/1/2021. Read SEC document |
| June 28, 2022 Filed Jun 30, 2022 21:00 UTC | CVS HEALTH Corp CVS · Entity 2884 | SaleCommon Stock | 38,873 | $95.00 | $3,692,935.00 |
DisclosureSEC source: 0001127602-22-018293 · form4.xml · nonDerivative · entry 6 Moriarty Thomas M · CIK 0001412221 · EVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 626,273 F1 · kind: All sales were effected pursuant to a Rule 10b5-1 plan. Read SEC document |
| June 28, 2022 Filed Jun 30, 2022 21:00 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionCommon Stock | 38,873 | $74.30 | $2,888,263.90 |
DisclosureSEC source: 0001127602-22-018293 · form4.xml · nonDerivative · entry 5 Moriarty Thomas M · CIK 0001412221 · EVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 665,146 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 28, 2022 Filed Jun 30, 2022 21:00 UTC | CVS HEALTH Corp CVS · Entity 2884 | SaleCommon Stock | 50,502 | $95.00 | $4,797,690.00 |
DisclosureSEC source: 0001127602-22-018293 · form4.xml · nonDerivative · entry 4 Moriarty Thomas M · CIK 0001412221 · EVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 626,273 F1 · kind: All sales were effected pursuant to a Rule 10b5-1 plan. Read SEC document |
| June 28, 2022 Filed Jun 30, 2022 21:00 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionCommon Stock | 50,502 | $54.19 | $2,736,703.38 |
DisclosureSEC source: 0001127602-22-018293 · form4.xml · nonDerivative · entry 3 Moriarty Thomas M · CIK 0001412221 · EVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 676,775 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 28, 2022 Filed Jun 30, 2022 21:00 UTC | CVS HEALTH Corp CVS · Entity 2884 | SaleCommon Stock | 49,279 | $95.00 | $4,681,505.00 |
DisclosureSEC source: 0001127602-22-018293 · form4.xml · nonDerivative · entry 2 Moriarty Thomas M · CIK 0001412221 · EVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 626,273 F1 · kind: All sales were effected pursuant to a Rule 10b5-1 plan. Read SEC document |
| June 28, 2022 Filed Jun 30, 2022 21:00 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionCommon Stock | 49,279 | $58.35 | $2,875,429.65 |
DisclosureSEC source: 0001127602-22-018293 · form4.xml · nonDerivative · entry 1 Moriarty Thomas M · CIK 0001412221 · EVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 675,552 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 03, 2022 Filed Apr 5, 2022 23:39 UTC | CVS HEALTH Corp CVS · Entity 2884 | Tax withholdingCommon Stock | 3,556 | $101.09 | $359,476.04 |
DisclosureSEC source: 0001127602-22-011640 · form4.xml · nonDerivative · entry 2 Moriarty Thomas M · CIK 0001412221 · EVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 735,349 F2 · shares: Surrender of shares in payment of taxes due upon the vesting and settlement of PSUs on April 1, 2022. Read SEC document |
| April 01, 2022 Filed Apr 5, 2022 23:39 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantStock Option · Derivative | 46,777 | $101.09 Strike: $101.09 | $4,728,686.93 |
DisclosureSEC source: 0001127602-22-011640 · form4.xml · derivative · entry 5 Moriarty Thomas M · CIK 0001412221 · EVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,777 Underlying: Common Stock · 46,777 shares Expires 2032-04-01 F3 · derivative.exercise_date: Option becomes exercisable in four equal annual installments, commencing 4/1/2023. Read SEC document |
| April 01, 2022 Filed Apr 5, 2022 23:39 UTC | CVS HEALTH Corp CVS · Entity 2884 | Tax withholdingCommon Stock | 105,854 | $101.09 | $10,700,780.86 |
DisclosureSEC source: 0001127602-22-011640 · form4.xml · nonDerivative · entry 1 Moriarty Thomas M · CIK 0001412221 · EVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 730,897 F1 · shares: Surrender of shares in payment of withholding taxes due upon the vesting and settlement of the PSUs. Read SEC document |
| March 15, 2022 Filed Mar 17, 2022 20:32 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionStock Option · Derivative | 51,361 | $0.00 Strike: $102.26 | $0.00 |
DisclosureSEC source: 0001127602-22-009725 · form4.xml · derivative · entry 6 Moriarty Thomas M · CIK 0001412221 · EVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 51,361 shares Expires 2022-04-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: All sales were effected pursuant to a Rule 10b5-1 plan. F2 · derivative.exercise_date: Option became exercisable in four equal annual installments, commencing 4/1/2016. Read SEC document |
| March 15, 2022 Filed Mar 17, 2022 20:32 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionCommon Stock | 51,361 | $102.26 | $5,252,175.86 |
DisclosureSEC source: 0001127602-22-009725 · form4.xml · nonDerivative · entry 2 Moriarty Thomas M · CIK 0001412221 · EVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 888,112 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: All sales were effected pursuant to a Rule 10b5-1 plan. Read SEC document |
| March 15, 2022 Filed Mar 17, 2022 20:32 UTC | CVS HEALTH Corp CVS · Entity 2884 | SaleCommon Stock | 51,361 | $105.00 | $5,392,905.00 |
DisclosureSEC source: 0001127602-22-009725 · form4.xml · nonDerivative · entry 1 Moriarty Thomas M · CIK 0001412221 · EVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 836,751 Read SEC document |
| February 21, 2022 Filed Feb 23, 2022 21:30 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock | 214,930 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-006300 · form4.xml · nonDerivative · entry 2 Moriarty Thomas M · CIK 0001412221 · EVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 836,751 F2 · shares: Represents shares earned by the reporting person pursuant to PSUs that were granted to the reporting person under the Issuer's 2017 Incentive Compensation Plan on June 5, 2019. The PSUs were earned based on the attainment of certain performance metrics, which performance metrics were certified by the Management and Planning Committee of the Board of Directors of the Issuer on February 21, 2022. Read SEC document |
| February 21, 2022 Filed Feb 23, 2022 21:30 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock | 572,542 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-006300 · form4.xml · nonDerivative · entry 1 Moriarty Thomas M · CIK 0001412221 · EVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 621,821 F1 · shares: Represents shares earned by the reporting person pursuant to certain performance stock units (the "PSUs"), which were granted to the reporting person under the Issuer's 2017 Incentive Compensation Plan on August 30, 2019. The PSUs were earned based on the attainment of certain performance metrics, which performance metrics were certified by the Management and Planning Committee of the Board of Directors of the Issuer on February 21, 2022. Read SEC document |
| May 10, 2021 Filed May 12, 2021 21:30 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionStock Option · Derivative | 109,469 | $0.00 Strike: $62.21 | $0.00 |
DisclosureSEC source: 0001127602-21-016436 · form4.xml · derivative · entry 6 Moriarty Thomas M · CIK 0001412221 · EVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,490 Underlying: Common Stock · 109,469 shares Expires 2025-04-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Option became exercisable in four equal annual installments, commencing 4/1/2019. Read SEC document |
| May 10, 2021 Filed May 12, 2021 21:30 UTC | CVS HEALTH Corp CVS · Entity 2884 | SaleCommon Stock | 109,469 | $86.00 | $9,414,334.00 |
DisclosureSEC source: 0001127602-21-016436 · form4.xml · nonDerivative · entry 2 Moriarty Thomas M · CIK 0001412221 · EVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: All sales were effected pursuant to a Rule 10b5-1 plan. Read SEC document |
| May 10, 2021 Filed May 12, 2021 21:30 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionCommon Stock | 109,469 | $62.21 | $6,810,066.49 |
DisclosureSEC source: 0001127602-21-016436 · form4.xml · nonDerivative · entry 1 Moriarty Thomas M · CIK 0001412221 · EVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 109,469 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 04, 2021 Filed May 6, 2021 21:53 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionStock Option · Derivative | 49,279 | $0.00 Strike: $58.34 | $0.00 |
DisclosureSEC source: 0001127602-21-015776 · form4.xml · derivative · entry 5 Moriarty Thomas M · CIK 0001412221 · EVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 147,837 Underlying: Common Stock · 49,279 shares Expires 2030-04-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The number of shares subject to the option were calculated using a 30-day average price. F2 · derivative.exercise_date: Option became exercisable in four equal annual installments, commencing 4/1/2021. Read SEC document |
| May 04, 2021 Filed May 6, 2021 21:53 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionCommon Stock | 49,279 | $58.34 | $2,874,936.86 |
DisclosureSEC source: 0001127602-21-015776 · form4.xml · nonDerivative · entry 1 Moriarty Thomas M · CIK 0001412221 · EVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,279 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 21, 2021 Filed Apr 23, 2021 20:57 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionStock Option · Derivative | 101,003 | $0.00 Strike: $54.19 | $0.00 |
DisclosureSEC source: 0001127602-21-014345 · form4.xml · derivative · entry 7 Moriarty Thomas M · CIK 0001412221 · EVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 101,004 Underlying: Common Stock · 101,003 shares Expires 2029-04-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Option became exercisable in four equal annual installments, commencing 4/1/2020. Read SEC document |
| April 21, 2021 Filed Apr 23, 2021 20:57 UTC | CVS HEALTH Corp CVS · Entity 2884 | SaleCommon Stock | 2,420 | $77.00 | $186,340.00 |
DisclosureSEC source: 0001127602-21-014345 · form4.xml · nonDerivative · entry 3 Moriarty Thomas M · CIK 0001412221 · EVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F2 · kind: All sales were effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| April 21, 2021 Filed Apr 23, 2021 20:57 UTC | CVS HEALTH Corp CVS · Entity 2884 | SaleCommon Stock | 101,003 | $77.00 | $7,777,231.00 |
DisclosureSEC source: 0001127602-21-014345 · form4.xml · nonDerivative · entry 2 Moriarty Thomas M · CIK 0001412221 · EVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,420 F1 · kind: All sales were effected pursuant to a Rule 10b5-1 plan. Read SEC document |
| April 21, 2021 Filed Apr 23, 2021 20:57 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionCommon Stock | 101,003 | $54.19 | $5,473,352.57 |
DisclosureSEC source: 0001127602-21-014345 · form4.xml · nonDerivative · entry 1 Moriarty Thomas M · CIK 0001412221 · EVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103,423 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 01, 2021 Filed Apr 2, 2021 21:43 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantStock Option · Derivative | 155,495 | $74.30 Strike: $74.30 | $11,553,278.50 |
DisclosureSEC source: 0001127602-21-012790 · form4.xml · derivative · entry 7 Moriarty Thomas M · CIK 0001412221 · EVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 155,495 Underlying: Common Stock · 155,495 shares Expires 2031-04-01 F4 · derivative.exercise_date: Option becomes exercisable in four equal installments, commencing 4/1/2022. Read SEC document |
| April 01, 2021 Filed Apr 2, 2021 21:43 UTC | CVS HEALTH Corp CVS · Entity 2884 | Tax withholdingCommon Stock | 2,350 | $74.30 | $174,605.00 |
DisclosureSEC source: 0001127602-21-012790 · form4.xml · nonDerivative · entry 3 Moriarty Thomas M · CIK 0001412221 · EVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,373 F3 · shares: Surrender of shares in payment of taxes due upon the vesting and settlement of a restricted stock unit award on April 1, 2021. Read SEC document |
| April 01, 2021 Filed Apr 2, 2021 21:43 UTC | CVS HEALTH Corp CVS · Entity 2884 | Tax withholdingCommon Stock | 61,095 | $74.30 | $4,539,358.50 |
DisclosureSEC source: 0001127602-21-012790 · form4.xml · nonDerivative · entry 2 Moriarty Thomas M · CIK 0001412221 · EVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,953 F2 · shares: Surrender of shares in payment of taxes due upon the vesting and settlement of the PSUs on April 1, 2021. Read SEC document |
| March 29, 2021 Filed Mar 30, 2021 21:01 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionStock Option · Derivative | 62,943 | $0.00 Strike: $74.29 | $0.00 |
DisclosureSEC source: 0001127602-21-012328 · form4.xml · derivative · entry 6 Moriarty Thomas M · CIK 0001412221 · EVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 62,943 shares Expires 2021-04-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Option became exercisable in four equal annual installments, commencing 4/1/2015. Read SEC document |
| March 29, 2021 Filed Mar 30, 2021 21:01 UTC | CVS HEALTH Corp CVS · Entity 2884 | SaleCommon Stock | 62,943 | $76.15 | $4,793,109.45 |
DisclosureSEC source: 0001127602-21-012328 · form4.xml · nonDerivative · entry 2 Moriarty Thomas M · CIK 0001412221 · EVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: All sales were effected pursuant to a Rule 10b5-1 plan. F2 · price: Represents weighted average sale price for this group of sales, which occurred on the same trading day. Multiple sales were executed, with sale prices ranging between $75.51 and $76.68 per share. Read SEC document |
| March 29, 2021 Filed Mar 30, 2021 21:01 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionCommon Stock | 62,943 | $74.29 | $4,676,035.47 |
DisclosureSEC source: 0001127602-21-012328 · form4.xml · nonDerivative · entry 1 Moriarty Thomas M · CIK 0001412221 · EVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,943 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 19, 2021 Filed Mar 23, 2021 22:15 UTC | CVS HEALTH Corp CVS · Entity 2884 | SaleCommon Stock | 49,211 | $74.15 | $3,648,995.65 |
DisclosureSEC source: 0001127602-21-011860 · form4.xml · nonDerivative · entry 1 Moriarty Thomas M · CIK 0001412221 · EVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Indirect · By GRAT Disclosed balance after: 18,226.0221 F1 · kind: All sales were effected pursuant to a Rule 10b5-1 plan. F2 · price: Represents weighted average sale price for this group of sales, which occurred on the same trading day. Multiple sales were executed, with sales prices ranging between $74.00 and $74.58 per share. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.